797 studies found for:    il-13
Show Display Options
Rank Status Study
21 Recruiting Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
Conditions: Allergic Rhinitis;   Perennial Allergic Rhinitis;   Non-seasonal Allergic Rhinitis
Interventions: Drug: AGR tablet;   Drug: Placebo (for AGR tablet and/or Active Comparator);   Drug: Active Comparator
22 Recruiting The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis
Condition: Other Allergic Rhinitis
Intervention: Procedure: nasal allergen provocation test
23 Completed A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: QAV680;   Drug: Mometasone Furoate
24 Completed The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: PF-03654764;   Drug: Allegra;   Drug: Allegra-D;   Drug: Placebo
25 Completed Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms
Condition: Seasonal Allergic Rhinitis
Interventions: Dietary Supplement: Lectranal;   Dietary Supplement: placebo
26 Recruiting NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Oxymetazoline;   Other: Hydroxyl-propyl-methyl cellulose powder;   Other: Placebo (lactose powder)
27 Completed A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults
Condition: Allergic Rhinitis
Interventions: Drug: JNJ-17166864;   Drug: Placebo
28 Not yet recruiting Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Other: Grass pollen sublingual immunotherapy tablet;   Drug: Control
29 Completed SD, IL-13 Production Rate in IPF
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: QAX576
30 Completed A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis
Conditions: Allergic Rhinitis;   Rhinitis, Allergic, Seasonal
Interventions: Drug: GSK256066;   Drug: azelastine hydrochloride
31 Recruiting the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Conditions: Perennial Allergic Rhinitis;   Probiotics;   Lactobacillus Paracasei GMNL-32 (eN-Lac®)
Interventions: Biological: eN-Lac®;   Other: Placebo
32 Completed Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
Conditions: Perennial Allergic Rhinitis;   Allergic Rhinitis;   Hay Fever
Intervention: Drug: Ciclesonide
33 Completed Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
Conditions: Perennial Allergic Rhinitis;   Allergic Rhinitis;   Hay Fever
Intervention: Drug: Ciclesonide
34 Completed A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
Conditions: Allergic Rhinitis;   Rhinitis, Allergic, Seasonal
Interventions: Drug: GSK256066;   Drug: fluticasone propionate
35 Recruiting Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
Condition: Allergic Rhinitis
Interventions: Drug: HollisterStier;   Drug: Normal saline
36 Terminated Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
Conditions: Rhinitis, Allergic, Seasonal;   Seasonal Allergic Rhinitis
Intervention: Drug: Fluticasone furoate nasal spray
37 Completed Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
Conditions: Seasonal Allergic Rhinitis;   Perennial Allergic Rhinitis
Intervention: Drug: GW685698X
38 Completed Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: ACT-129968;   Drug: Placebo;   Drug: Cetirizine
39 Completed A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Intervention: Drug: Ciclesonide nasal spray, 50 μg per actuation.
40 Completed Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
Condition: Perennial Allergic Rhinitis (PAR)
Intervention: Drug: Beclomethasone Dipropionate (BDP) Nasal Aerosol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years